Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CTOR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
CTOR
Citius Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
CTOR
Citius Oncology, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CTOR, solid
LLY, dashed
CTOR
Citius Oncology, Inc.
Change
0.51
▲
+1.38%
· post 0.51
Mkt cap
$55.0M
Revenue
$1M
Q3 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
CTOR
Citius Oncology, Inc.
vs
LLY
ELI Lilly & Co
0.51
▲
+1.38%
post 0.51
Price
1,360.90
▼
−0.28%
post 1,358.90
$55.0M
Mkt cap
$1.2T
Q3 FY26
$1M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
CTOR
0.51
▲
+1.38%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26